Journal of Physiology and Biochemistry

, Volume 68, Issue 3, pp 307–318 | Cite as

Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin–nicotinamide-induced experimental diabetic rats

  • T. Annadurai
  • A. R. Muralidharan
  • T. Joseph
  • M. J. Hsu
  • P. A. Thomas
  • P. Geraldine
Original Paper

Abstract

In the present study, the putative antihyperglycemic and antioxidant effects of a flavanone, naringenin, were evaluated in comparison with those of glyclazide, a standard drug for therapy of diabetes mellitus. Diabetes was induced experimentally in 12-h-fasted rats by intraperitoneal injections of first streptozotocin (50 mg/kg b.w.) and then of nicotinamide (110 mg/kg b.w.) after a 15-min interval. Untreated diabetic rats revealed the following in comparison with normal rats: significantly higher mean levels of blood glucose and glycosylated hemoglobin, significantly lower mean levels of serum insulin, significantly lower mean activities of pancreatic antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, glutathione-S-transferase), significantly lower mean levels of plasma non-enzymatic antioxidants (reduced glutathione, vitamin C , vitamin E), significantly elevated mean levels of pancreatic malondialdehyde (MDA) and significantly elevated mean activities of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH). Following oral administration of naringenin (50 mg/kg b.w./day) to diabetic rats for 21 days, the following observations were made in comparison with untreated diabetic rats: significantly lower mean levels of fasting blood glucose and glycosylated hemoglobin, significantly elevated serum insulin levels, significantly higher mean activities of pancreatic enzymatic antioxidants, significantly higher mean levels of plasma non-enzymatic antioxidants, lower mean pancreatic tissue levels of MDA and lower mean activities of ALT, AST, ALP and LDH in serum. The values obtained in the naringenin-treated animals approximated those observed in glyclazide-treated animals. Histopathological studies appeared to suggest a protective effect of naringenin on the pancreatic tissue in diabetic rats. These results suggest that naringenin exhibits antihyperglycemic and antioxidant effects in experimental diabetic rats.

Keywords

Diabetes Naringenin Streptozotocin–nicotinamide Oxidative stress 

References

  1. 1.
    al-Shamaony L, al-Khazraji SM, Twaij HA (1994) Hypoglycaemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol 43:167–171PubMedCrossRefGoogle Scholar
  2. 2.
    Ardestani A, Yazdanparast R, Jamshidi S (2008) Therapeutic effects of Teucrium polium extract on oxidative stress in pancreas of streptozotocin-induced diabetic rats. J Med Food 11:525–532PubMedCrossRefGoogle Scholar
  3. 3.
    Badary OA, Abdel-Maksoud S, Ahmed WA, Owieda GH (2005) Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sci 76:2125–2135PubMedCrossRefGoogle Scholar
  4. 4.
    Bagri P, Ali M, Aeri V, Bhowmik M, Sultana S (2009) Antidiabetic effect of Punica granatum flowers: effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Food Chem Toxicol 47:50–54PubMedCrossRefGoogle Scholar
  5. 5.
    Baumann J, Wurm G, Fv B (1980) Prostaglandin synthetase inhibition by flavonoids and phenolic compounds in relation to their O2—scavenging properties. Arch Pharm (Weinheim) 313:330–337CrossRefGoogle Scholar
  6. 6.
    Bekris LM, Shephard C, Peterson M, Hoehna J, Van Yserloo B et al (2005) Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset. Autoimmunity 38:567–575PubMedCrossRefGoogle Scholar
  7. 7.
    Benavente-García O, Castillo J (2008) Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem 56:6185–6205PubMedCrossRefGoogle Scholar
  8. 8.
    Bradford M (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMedCrossRefGoogle Scholar
  9. 9.
    Burton GW, Cheng SC, Webb A, Ingold KU (1986) Vitamin E in young and old human red blood cells. Biochim Biophys Acta 860:84–90PubMedCrossRefGoogle Scholar
  10. 10.
    Ceriello A (2000) Oxidative stress and glycemic regulation. Metabolism 49:27–29PubMedCrossRefGoogle Scholar
  11. 11.
    Chance B, Greenstein DS, Roughton FJW (1952) The mechanism of catalase action. I. Steady-state analysis. Arch Biochem Biophys 37:301–321PubMedCrossRefGoogle Scholar
  12. 12.
    Coskun O, Kanter M, Korkmaz A, Oter S (2005) Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol Res 51:117–123PubMedCrossRefGoogle Scholar
  13. 13.
    Desai ID (1984) Vitamin E analysis methods for animal tissues. Methods Enzymol 105:138–147PubMedCrossRefGoogle Scholar
  14. 14.
    Drury RAD, Wallington EA (1980) Carleton's histological technique. Oxford University Press, New YorkGoogle Scholar
  15. 15.
    Du G, Jin L, Han X, Song Z, Zhang H et al (2009) Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasis. Cancer Res 69:3205–3212PubMedCrossRefGoogle Scholar
  16. 16.
    Gorogawa S-i, Kajimoto Y, Umayahara Y, Kaneto H, Watada H et al (2002) Probucol preserves pancreatic β-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res Clin Pract 57:1–10PubMedCrossRefGoogle Scholar
  17. 17.
    Gregus Z, Fekete T, Halaszi E, Klaassen CD (1996) Lipoic acid impairs glycine conjugation of benzoic acid and renal excretion of benzoylglycine. Drug Metab Dispos 24:682–688PubMedGoogle Scholar
  18. 18.
    Habig WH, Jakoby WB (1981) Assays for differentiation of glutathione S-transferases. Methods Enzymol 77:398–405PubMedCrossRefGoogle Scholar
  19. 19.
    Halliwell B (2000) Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc Res 47:410–418PubMedCrossRefGoogle Scholar
  20. 20.
    Halliwell B, Gutteridge JM, Cross CE (1992) Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 119:598–620PubMedGoogle Scholar
  21. 21.
    Jin L, Xue HY, Jin LJ, Li SY, Xu YP (2008) Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes. Eur J Pharmacol 582:162–167PubMedCrossRefGoogle Scholar
  22. 22.
    Kajimoto Y, Kaneto H (2004) Role of oxidative stress in pancreatic beta-cell dysfunction. Ann N Y Acad Sci 1011:168–176PubMedCrossRefGoogle Scholar
  23. 23.
    Kaleem MAM, Ahmed QU, Bano B (2006) Antidiabetic and antioxidant activity of Annona squamosa extract in streptozotocin-induced diabetic rats. Singapore Med J 47:670–675PubMedGoogle Scholar
  24. 24.
    Kamalakkannan N, Prince PSM (2006) Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic Wistar rats. Basic Clin Pharmacol Toxicol 98:97–103PubMedCrossRefGoogle Scholar
  25. 25.
    Kameswara Rao B, Appa Rao C (2001) Hypoglycemic and antihyperglycemic activity of Syzygium alternifolium (Wt.) Walp. seed extracts in normal and diabetic rats. Phytomedicine 8:88–93CrossRefGoogle Scholar
  26. 26.
    Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y et al (1999) Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48:2398–2406PubMedCrossRefGoogle Scholar
  27. 27.
    Kannappan S, Anuradha CV (2010) Naringenin enhances insulin-stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome. Eur J Nutr 49:101–109PubMedCrossRefGoogle Scholar
  28. 28.
    Kinalski M, Sledziewski A, Telejko B, Zarzycki W, Kinalska I (2000) Lipid peroxidation and scavenging enzyme activity in streptozotocin-induced diabetes. Acta Diabetol 37:179–183PubMedCrossRefGoogle Scholar
  29. 29.
    King J (1965) The dehydrogenases or oxidoreductases-lactate dehydrogenase; Van D, editor. Nostrand Company Limited, London, pp 91–208Google Scholar
  30. 30.
    King J (1965) The transferases-alanine and aspartate transaminases; Van D, editor. Nostrand Company Limited, London, pp 121–138Google Scholar
  31. 31.
    Leclercq IA, Da Silva MA, Schroyen B, Van Hul N, Geerts A (2007) Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol 47:142–156PubMedCrossRefGoogle Scholar
  32. 32.
    LeDoux SP, Hall CR, Forbes PM, Patton NJ, Wilson GL (1988) Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity. Diabetes 37:1015–1019PubMedCrossRefGoogle Scholar
  33. 33.
    Liu Z, Li J, Zeng Z, Liu M, Wang M (2008) The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats. Chem Biol Interact 173:68–75PubMedCrossRefGoogle Scholar
  34. 34.
    Maritim AC, Sanders RA, Watkins JB (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24–38PubMedCrossRefGoogle Scholar
  35. 35.
    Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474PubMedCrossRefGoogle Scholar
  36. 36.
    Masiello P, Broca C, Gross R, Roye M, Manteghetti M et al (1998) Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47:224–229PubMedCrossRefGoogle Scholar
  37. 37.
    Mates JM, Sanchez-Jimenez F (1999) Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 4:D339–D345PubMedCrossRefGoogle Scholar
  38. 38.
    McCord JM (1979) Superoxide dismutase; Tattazzi M, Scandalios, JG, Whitt, GS editor. New York: Alan R.Liss Inc.Google Scholar
  39. 39.
    McLennan SV, Heffernan S, Wright L, Rae C, Fisher E et al (1991) Changes in hepatic glutathione metabolism in diabetes. Diabetes 40:344–348PubMedCrossRefGoogle Scholar
  40. 40.
    Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67–78PubMedCrossRefGoogle Scholar
  41. 41.
    Mullarkey CJ, Edelstein D, Brownlee M (1990) Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173:932–939PubMedCrossRefGoogle Scholar
  42. 42.
    Mulvihill EE, Allister EM, Sutherland BG, Telford DE, Sawyez CG et al (2009) Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes 58:2198–2210PubMedCrossRefGoogle Scholar
  43. 43.
    Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRefGoogle Scholar
  44. 44.
    Omaye ST, Turnbull JD, Sauberlich HE (1979) Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol 62:3–11PubMedCrossRefGoogle Scholar
  45. 45.
    Ortiz-Andrade RR, Sanchez-Salgado JC, Navarrete-Vazquez G, Webster SP, Binnie M et al (2008) Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes Metab 10:1097–1104PubMedCrossRefGoogle Scholar
  46. 46.
    Palsamy P, Subramanian S (2008) Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin–nicotinamide induced experimental diabetic rats. Biomedicine & Pharmacotherapy 62: 598-605.Google Scholar
  47. 47.
    Palsamy P, Subramanian S (2010) Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin–nicotinamide-induced diabetic rats. J Cell Physiol 224:423–432PubMedCrossRefGoogle Scholar
  48. 48.
    Paolisso G, D'Amore A, Di Maro G, Galzerano D, Tesauro P et al (1993) Evidence for a relationship between free radicals and insulin action in the elderly. Metabolism 42:659–663PubMedCrossRefGoogle Scholar
  49. 49.
    Pari L, Karthikesan K, Menon V (2010) Comparative and combined effect of chlorogenic acid and tetrahydrocurcumin on antioxidant disparities in chemical induced experimental diabetes. Mol Cell Biochem 341:109–117PubMedCrossRefGoogle Scholar
  50. 50.
    Park JH, Jin CY, Lee BK, Kim GY, Choi YH et al (2008) Naringenin induces apoptosis through downregulation of Akt and caspase-3 activation in human leukemia THP-1 cells. Food Chem Toxicol 46:3684–3690PubMedCrossRefGoogle Scholar
  51. 51.
    Punithavathi VR, Prince PSM, Kumar R, Selvakumari J (2011) Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. Eur J Pharmacol 650:465–471PubMedCrossRefGoogle Scholar
  52. 52.
    Rakieten N, Rakieten ML, Nadkarni MR (1963) Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 29:91–98Google Scholar
  53. 53.
    Ramesh B, Saravanan R, Pugalendi KV (2005) Influence of sesame oil on blood glucose, lipid peroxidation, and antioxidant status in streptozotocin diabetic rats. J Med Food 8:377–381PubMedCrossRefGoogle Scholar
  54. 54.
    Ravi K, Ramachandran B, Subramanian S (2004) Protective effect of Eugenia jambolana seed kernel on tissue antioxidants in streptozotocin-induced diabetic rats. Biol Pharm Bull 27:1212–1217PubMedCrossRefGoogle Scholar
  55. 55.
    Renugadevi J, Prabu SM (2009) Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology 256:128–134PubMedCrossRefGoogle Scholar
  56. 56.
    Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG et al (1973) Selenium: biochemical role as a component of glutathione peroxidase. Science 179:588–590PubMedCrossRefGoogle Scholar
  57. 57.
    Saravanan G, Ponmurugan P (2010) Beneficial effect of S-allylcysteine (SAC) on blood glucose and pancreatic antioxidant system in streptozotocin diabetic rats. Plant Foods Hum Nutr 65:374–378PubMedCrossRefGoogle Scholar
  58. 58.
    Shi Y, Dai J, Liu H, Li RR, Sun PL et al (2009) Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-kappaB activity in a murine model of asthma. Can J Physiol Pharm 87:729–735CrossRefGoogle Scholar
  59. 59.
    Sinha AK (1972) Colorimetric assay of catalase. Anal Biochem 47:389–394PubMedCrossRefGoogle Scholar
  60. 60.
    Sivakumar S, Subramanian SP (2009) Pancreatic tissue protective nature of D-pinitol studied in streptozotocin-mediated oxidative stress in experimental diabetic rats. Eur J Pharmacol 622:65–70PubMedCrossRefGoogle Scholar
  61. 61.
    Strain JJ (1991) Disturbances of micronutrient and antioxidant status in diabetes. Proc Nutr Soc 50:591–604PubMedCrossRefGoogle Scholar
  62. 62.
    Szymonik-Lesiuk S, Czechowska G, Stryjecka-Zimmer M, Slomka M, Madro A et al (2003) Catalase, superoxide dismutase, and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication. J Hepatobiliary Pancreat Surg 10:309–315PubMedCrossRefGoogle Scholar
  63. 63.
    Thomas CE, McLean LR, Parker RA, Ohlweiler DF (1992) Ascorbate and phenolic antioxidant interactions in prevention of liposomal oxidation. Lipids 27:543–550PubMedCrossRefGoogle Scholar
  64. 64.
    van Acker FAA, Schouten O, Haenen GRMM, van der Vijgh WJF, Bast A (2000) Flavonoids can replace [alpha]-tocopherol as an antioxidant. FEBS Lett 473:145–148PubMedCrossRefGoogle Scholar
  65. 65.
    West IC (2000) Radicals and oxidative stress in diabetes. Diabet Med 17:171–180PubMedCrossRefGoogle Scholar
  66. 66.
    Wilcox LJ, Borradaile NM, Huff MW (1999) Antiatherogenic properties of naringenin, a citrus flavonoid. Cardiovasc Drug Rev 17:160–178CrossRefGoogle Scholar
  67. 67.
    Yan H, Harding JJ (1997) Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase. Biochem J 328(Pt 2):599–605PubMedGoogle Scholar
  68. 68.
    Yen F-L, Wu T-H, Lin L-T, Cham T-M, Lin C-C (2009) Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl4-induced acute liver failure. Pharm Res 26: 893-902-902.Google Scholar
  69. 69.
    Zimmerman HJ, Seef LB (1970) Enzymes in hepatic disease; Goodly EL, editor. Philadephia: Lea and Febiger. pp. 1-38.Google Scholar

Copyright information

© University of Navarra 2012

Authors and Affiliations

  • T. Annadurai
    • 1
  • A. R. Muralidharan
    • 1
  • T. Joseph
    • 2
  • M. J. Hsu
    • 3
  • P. A. Thomas
    • 2
  • P. Geraldine
    • 1
  1. 1.Department of Animal Science, School of Life SciencesBharathidasan UniversityTiruchirappalliIndia
  2. 2.Thomas Diagnostic and Research CentreTiruchirappalliIndia
  3. 3.Department of Pharmacology, School of Medicine, College of MedicineTaipei Medical UniversityTaipeiTaiwan

Personalised recommendations